Hot Casino Stocks To Invest In 2018

Officials in China’s gambling enclave of Macau have raised concerns about sexual misconduct allegations against casino mogul Steve Wynn.

The intervention adds to mounting pressure on Wynn and Wynn Macau (WYNMF), the business that generates most of the profit for his gambling empire. The Hong Kong-listed division of Wynn Resorts (WYNN) has lost more than $2 billion in stock market value over the past two days.

The plunge comes after a Wall Street Journal investigation uncovered decades of sexual misconduct allegations made against Wynn, the 76-year-old founder and CEO of Wynn Resorts. The company’s board of directors has launched an investigation into the allegations, which Wynn has denied.

In a statement Tuesday, Macau’s Gaming Inspection and Coordination Bureau said it had expressed concern about reports of Wynn’s “involvement in inappropriate behavior” during a meeting with Wynn Macau’s leadership. It said it has asked the company for more information.

Hot Casino Stocks To Invest In 2018: Teladoc, Inc.(TDOC)

Advisors’ Opinion:

  • [By Steve Symington, Rich Smith, and Keith Speights]

    But from an investor’s perspective, that raises the question: Are there other stocks that could offer similar returns?So we asked three top Motley Fool contributors to each pick a stock they believe hasNVIDIA-like return potential. Read on to see why they chose CalAmp (NASDAQ:CAMP), Kratos Defense & Security (NASDAQ:KTOS), and Teladoc (NYSE:TDOC).

  • [By Chris Hill]

    In today’s episode of MarketFoolery, host Chris Hill and Motley Fool analyst Jason Moser go through some of the messy metrics from this quarter and explain which areas long-term investors should focus on to track how the company is doing. Also, Texas Roadhouse(NASDAQ:TXRH) clocked in another good quarter, but how can the restaurant grow from here? Virtual healthcare provider Teladoc (NYSE:TDOC)reports earnings later today, and long-term investors should watch for progress in these key metrics. Tune in to find out more.

  • [By Keith Speights]

    CVS Health isn’t starting from scratch in developing its virtual care services, though. Merlo stated that the company is partnering with telehealth leaderTeladoc (NYSE:TDOC). He said CVS will use Teladoc as the engine to provides telehealth services through CVS Health’s app. The services will be provided by the company’s MinuteClinic as well as other providers. Merlo added that Teladoc is basically “private labeling our telehealth program.”

Hot Casino Stocks To Invest In 2018: Advantage Lithium Corp. (AVLIF)

Advisors’ Opinion:

  • [By ]

    Advantage Lithium (OTCQX:AVLIF) is a strategic advanced junior lithium exploration company that operates between Lithium Americas and Orocobre in the Cauchari-Olaroz basin. Orocobre is the largest shareholder in the company with a 30% equity stake, coupled with a 25% interest in the project. Over the past few months, the company has been moving towards completing the second stage of its drilling campaign, which will be completed in May 2018 and will then be followed on with an updated Natural Resource Estimate Study. This will allow the company to move into phase three of its drilling efforts, which will utilize larger drills to further define the resource, with a Feasibility Study expected to be completed in the first part of 2019.


    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

Hot Casino Stocks To Invest In 2018: Stag Industrial, Inc.(STAG)

Advisors’ Opinion:

  • [By Lee Jackson]

    STAG Industrial Inc. (NYSE: STAG) offers investors a 5.8% yield. Share recently traded hands at $24.35 apiece, in a 52-week range of $22.42 to $28.85. The consensus target price is $27.73.

Hot Casino Stocks To Invest In 2018: Advantage Oil & Gas Ltd(AAV)

Advisors’ Opinion:

  • [By Max Byerly]

    Advantage Oil & Gas (NYSE:AAV) (TSE:AAV) released its quarterly earnings data on Thursday. The oil and gas company reported $0.04 EPS for the quarter, missing the Zacks’ consensus estimate of $0.07 by ($0.03), MarketWatch Earnings reports. The business had revenue of $58.07 million during the quarter, compared to analyst estimates of $62.09 million. Advantage Oil & Gas had a net margin of 39.22% and a return on equity of 2.98%.

Hot Casino Stocks To Invest In 2018: Cellectis S.A.(CLLS)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, small cap clinical-stage biopharmaceutical stock Cellectis SA (NASDAQ: CLLS) reported that they had received notice fromFDA that a clinical hold was placed on both UCART123 ongoing Phase 1 studies -in acute myeloid leukemia (AML) and in blastic plasmacytoid dendritic cell neoplasm (BPDCN). The clinical hold was initiated after Cellectis reported one fatality in the BPDCN clinical trial (ABC study) with the Company now working closelywith the investigators and the FDA in order to resume the trials with an amended protocol including a lowered dosing of UCART123. The FDA has a detailed page about clinical holds which mentions:

  • [By Lisa Levin]

    Cellectis SA (ADR) (NASDAQ: CLLS) shares dropped 20 percent to $25.70 after announcing FDA clinical hold of UCART123 studies.

    Shares of Opiant Pharmaceuticals Inc (NASDAQ: OPNT) were down 10 percent to $35.20. Opiant Pharma named David O'Toole as CFO.